Differences in regulations, technical standards and national medical cultures across EU member states created a highly segmented pharmaceutical market in Europe prior to the implementation of the Single Market Programme. The subsequent reduction in non-tariff barriers to trade would be expected...

Should economies that promote themselves as export platforms for FDI be expected to experience relatively high levels of export spillovers from foreign to host-country enterprises? To investigate how export decisions of host-country enterprises are associated with the presence and export...

Differences in regulations, technical standards and national medical cultures across EU member states created a highly segmented pharmaceutical market in Europe prior to the implementation of the Single Market Programme. The subsequent reduction in non-tariff barriers to trade would be expected...

There is increasing growth in export platform foreign direct investment (EPFDI) globally, reflecting both the international fragmentation of production associated with globalisation and the adoption of policies to promote this type of investment as part of the “export led growth” strategies...